Editorial Notice: This content is for educational purposes only and does not constitute medical advice. Ingredient research discussed below relates to compounds as studied in published scientific literature — not to the specific commercial product Mycolean unless explicitly noted. In vitro, animal model, and human clinical trial findings are distinguished throughout. Individual results vary. These statements have not been evaluated by the Food and Drug Administration. Always consult a qualified healthcare provider before beginning any supplement or nootropic product.
By Top Shelf Mushrooms Editorial Team
Quick Answer: Mycolean lists different ingredients across two official sources (product page vs. FAQ). The compounds confirmed across both lists — Lion’s Mane, 5-HTP, Rhodiola Rosea, and Vitamin B12 — have meaningful research support at studied dosages. Phenylethylamine HCl (PEA) and Mimosa Hostilis Root, which appear only on the product page, have narrower and more interaction-sensitive profiles. No Supplement Facts panel with per-ingredient dosages is publicly available, which means research comparisons are directional only — not product-specific.
Reading ingredient research on a product with no disclosed dosages requires a specific analytical lens. The compounds in Mycolean’s formula — across both of its official ingredient lists — are not obscure or invented. They have published research profiles. What the research can tell you is what these compounds do at studied doses and in studied populations. What it cannot tell you — because the brand has not disclosed this information — is whether Mycolean’s formulation reaches any threshold that the research defines as meaningful.
This article covers what the published evidence actually says about each named compound, rates the quality of that evidence honestly, and notes the specific gaps that undisclosed dosing creates. For the full review of pricing, policies, and the cross-source ingredient discrepancy, see our Mycolean review.
How to Read Supplement Research
Peer-reviewed supplement research is graded in quality from in vitro (cell studies) to animal models to small human trials to randomized controlled trials (RCTs) to systematic reviews and meta-analyses. In vitro findings are mechanistically useful but don’t confirm human effects. Animal model findings suggest physiological plausibility but don’t predict human response with reliability. Human RCTs are the standard that matters clinically.
Effect size matters as much as statistical significance. A study can show a statistically significant effect that is too small to be meaningful to a consumer. Studies that don’t compare findings to placebo or include blinding may overstate effects through expectancy bias. Studies on isolated compounds in controlled conditions may not replicate in multi-ingredient proprietary blends at undisclosed dosages.
When we say the research on a compound is “strong,” we mean multiple RCTs show consistent effects at defined doses in human subjects. When we say it is “moderate,” we mean there are human trials with positive findings but limited replication, sample size concerns, or dose uncertainty. When we say it is “limited,” we mean mechanistic or animal evidence is present but human clinical data is insufficient to draw confident conclusions.
The Dose Math Framework
Mycolean does not publish a Supplement Facts panel with per-ingredient dosages. Both official ingredient lists present compound names only. This is the most significant transparency gap in the product — one that prevents direct comparison between what Mycolean contains and what research protocols use.
What we can document: the brand’s FAQ references “liposomal technology” as the delivery method, which is designed to improve bioavailability of compounds that are otherwise rapidly metabolized (this is especially relevant for PEA). Liposomal delivery, if effective, means a lower absolute dose may achieve effects comparable to a higher unencapsulated dose. However, this claim cannot be independently verified without dosage disclosure and third-party testing confirmation.
For comparison, transparent functional mushroom supplement products in the same market disclose per-species dosages. Our review of Ankhway’s 10-species gummies found per-species dosages listed. Our examination of cordyceps dose research establishes what meaningful doses in that compound class look like. Mycolean’s formula does not permit that level of evaluation.
5-HTP (5-Hydroxytryptophan) — Research Overview
5-HTP is a naturally occurring amino acid and the direct precursor to serotonin. Unlike tryptophan, it crosses the blood-brain barrier efficiently and raises central serotonin levels measurably. It is present in both of Mycolean’s official ingredient lists — one of the four compounds confirmed across both sources.
Evidence quality: Moderate to Strong for mood and anxiety support; dose-dependent. Multiple randomized controlled trials have examined 5-HTP for depression, anxiety, and sleep quality. The dosing used in most clinical research runs from 50mg to 300mg daily, with the lower range (50mg three times daily) showing effects in mood regulation studies. The Memorial Sloan Kettering Cancer Center and PoisonControl.org both document 5-HTP’s mechanism and interaction profile in clinical reference materials.
What the research does not support: marketing language that equates 5-HTP to a psychedelic experience. Serotonin elevation produces mood stabilization and reduced anxiety — not visual effects, not hallucinations, not the acute euphoria of alcohol. Any experiential effects attributed to 5-HTP in product marketing that go beyond mood support and reduced anxiety are not consistent with the published pharmacology.
Critical interaction note: 5-HTP must not be combined with SSRIs, MAOIs, tricyclic antidepressants, or other serotonergic medications without physician supervision. The theoretical risk of serotonin syndrome — a potentially life-threatening condition — is documented in case reports and acknowledged by the brand in its own FAQ. See the full Mycolean safety guide for specifics.
Rhodiola Rosea — Research Overview
Rhodiola Rosea is an adaptogen with active compounds identified as rosavins and salidrosides. It is present in both of Mycolean’s official ingredient lists and is one of the better-studied adaptogens in the functional supplement category.
Evidence quality: Moderate. A systematic review published in Phytomedicine evaluated 36 clinical trials on Rhodiola and found consistent, modest effects on perceived stress, mental fatigue, and mood under high-stress conditions. The compound appears to modulate the HPA axis and influence cortisol response, with effects most pronounced in people experiencing sustained stress rather than healthy individuals at rest.
Rhodiola’s mechanism is not fast-acting in the way alcohol or PEA are. It is an adaptogen — its benefits build with consistent use and are most relevant to baseline stress management rather than producing an acute experience. Products positioning Rhodiola as contributing to immediate mood elevation are describing a mechanism it does not actually have.
Research doses: Most clinical studies use 200mg to 680mg of standardized Rhodiola extract (3% rosavins, 1% salidroside) per day. Without dosage disclosure, it is not possible to determine whether Mycolean’s Rhodiola content reaches the threshold used in positive trials.
Phenylethylamine HCl (PEA) — Research Overview
PEA appears on Mycolean’s product page ingredient list but not in the FAQ’s ingredient answer — one of the two compounds in the inter-source discrepancy. Phenylethylamine is a naturally occurring monoamine compound that stimulates the release of dopamine and norepinephrine. It is sometimes called the “trace amine” for its role in mood and attention regulation.
Evidence quality: Limited for oral supplementation. PEA is rapidly metabolized by monoamine oxidase (MAO), which means oral PEA is largely broken down before producing central effects. This rapid degradation is the primary challenge in PEA supplementation — the compound’s short half-life limits practical utility unless delivery is modified or combined with MAO inhibitors. The “liposomal technology” Mycolean references may address this; the claim cannot be independently verified at this time.
High-quality human RCTs on oral PEA supplementation at consumer dosing levels are limited. The mechanistic basis for mood effects is established in the pharmacology literature, but translating that mechanism to a meaningful consumer experience through oral supplementation faces the metabolic challenge described above.
Critical safety note: PEA should never be combined with MAOI medications. The interaction can produce hypertensive crisis. If Mycolean contains PEA as stated on the product page, it is categorically unsafe for anyone on MAOI-class antidepressants or any drug with MAOI activity. This includes some older antidepressants, certain Parkinson’s medications, and the antibiotic linezolid.
Lion’s Mane (Hericium erinaceus) — Research Overview
Lion’s Mane is the most clinically established functional mushroom in the cognitive support space. It contains hericenones (from the fruiting body) and erinacines (from the mycelium), both of which have demonstrated the ability to stimulate nerve growth factor (NGF) synthesis in preclinical research. Lion’s Mane appears in both of Mycolean’s official ingredient lists.
Evidence quality: Moderate to Strong, with growing human trial base. A 2023 double-blind randomized controlled trial by Docherty, Doughty, and Smith at Northumbria University (doi:10.3390/nu15224842) found that a single dose of 1.8g Hericium erinaceus improved reaction time on the Stroop task at 60 minutes post-dose in healthy adults aged 18 to 45. A 2025 systematic review in Frontiers in Nutrition (doi:10.3389/fnut.2025.1641246) evaluated 26 studies on Hericium erinaceus and documented consistent findings around neuroprotective properties and cognitive support. A 2025 narrative review in Nutrition Research Reviews (doi:10.1017/S0954422425000058) examined Lion’s Mane’s potential in Alzheimer’s disease prevention, noting the growing body of evidence on NGF-mediated neuroprotection.
The research uses solid-form extracts with specific dosages — typically 1 to 3 grams per day for cognitive support outcomes in human trials. Whether the Lion’s Mane in Mycolean’s liquid proprietary blend reaches a comparable dosage is unknown. For a deeper look at Lion’s Mane’s research profile independent of any product, see our Lion’s Mane research library entry. For how Lion’s Mane functions in combination products, see our guide on how multi-mushroom blends work.
Mimosa Hostilis Root — Research Overview
Mimosa Hostilis Root (Mimosa tenuiflora) appears on Mycolean’s product page ingredient list but is absent from the FAQ’s ingredient answer — making it one of the two compounds whose presence in the actual formula is officially unresolved across the brand’s own documentation.
The plant’s root bark is known to contain trace quantities of DMT (N,N-Dimethyltryptamine), a compound classified as Schedule I under U.S. federal law. The plant itself is not scheduled. Traditional use of Mimosa Hostilis in ceremonial preparations relied on the root bark specifically because of its tryptamine content. Research on Mimosa Hostilis as a standalone oral supplement is extremely limited — essentially absent from the peer-reviewed clinical literature as a mood or cognitive supplement in the Western dietary supplement framework.
This review intentionally does not provide speculative research extrapolation for Mimosa Hostilis in the context of this product because: (1) the compound appears on only one of the two official ingredient sources, creating source uncertainty; (2) the pharmacological mechanism in the context of this formula is not established; (3) the research basis for oral supplementation at consumer doses is insufficient to present as meaningful evidence. Buyers with specific concerns about this ingredient should contact Myco Distribution LLC directly at support@mycolean.com before purchasing.
What This Means for Product Selection
The compounds in Mycolean with the strongest research support — 5-HTP, Rhodiola Rosea, and Lion’s Mane — are genuinely studied ingredients with documented mechanisms. The research on each is directionally positive for mood support, stress response, and cognitive function respectively. None of them, individually or in combination, produces the psychedelic-adjacent experiential effects Mycolean’s marketing describes at its most vivid. The marketing framing and the pharmacology tell different stories.
For buyers choosing between products in the alcohol alternative drink category based on ingredient evidence, the transparency question is the gating factor. A product that discloses per-ingredient dosages permits comparison to research conditions. Mycolean does not disclose dosages, which means evaluating whether it achieves clinically meaningful levels of any ingredient is not currently possible from the outside.
For the full comparison of Mycolean against other products in this category with methodology disclosed, see our alcohol alternative drinks comparison. For drug interaction specifics relevant to these compounds, see the Mycolean safety guide.
Frequently Asked Questions
Does 5-HTP actually improve mood?
5-HTP is a serotonin precursor that crosses the blood-brain barrier and raises serotonin levels. Multiple randomized controlled trials and systematic reviews support its effects on mood, particularly in the context of mild to moderate depression and anxiety. The starting dose used in most clinical research is 50mg taken up to three times daily. Consumer beverage products that include 5-HTP rarely disclose per-serving dosages, making it impossible to compare formulations to research conditions. At clinically studied doses, the evidence is meaningful. At undisclosed doses in a proprietary blend, the effect magnitude cannot be independently evaluated. Anyone currently taking SSRIs, MAOIs, or other serotonergic medications should not use 5-HTP without physician review due to the risk of serotonin syndrome.
What does Rhodiola Rosea actually do?
Rhodiola Rosea is an adaptogen with a moderate evidence base for effects on perceived stress, mental fatigue, and energy. A 2022 systematic review in Phytomedicine evaluated 36 clinical trials and found consistent but modest effects across stress, mood, and fatigue outcomes. Rhodiola’s active compounds — rosavins and salidrosides — are thought to modulate the HPA axis and influence cortisol response. Effects are most pronounced in high-stress conditions and are not fast-acting. Standardized extracts with disclosed rosavins and salidroside content are used in most clinical research; products that don’t specify standardization may use ingredients with variable active content.
Is Phenylethylamine HCl (PEA) safe and effective?
Phenylethylamine HCl (PEA) stimulates dopamine and norepinephrine release, with a typically short-lived effect due to rapid MAO metabolism. Human evidence at consumer dosing levels is limited. More critically, PEA must not be combined with MAOI-class medications under any circumstances — the interaction can produce dangerous hypertensive episodes. Anyone taking MAOIs, including certain antidepressants and the antibiotic linezolid, must avoid products containing PEA.
What does Lion’s Mane actually do in a liquid product?
Lion’s Mane (Hericium erinaceus) contains hericenones and erinacines associated with nerve growth factor (NGF) stimulation. Human clinical evidence is growing: a 2023 double-blind RCT at Northumbria University (doi:10.3390/nu15224842) found improved reaction time at 60 minutes post-dose with 1.8g in healthy adults. However, this research used solid-form extracts with standardized dosages. Liquid products with undisclosed dosages and unspecified extraction methods cannot be directly compared to these conditions.
What is Mimosa Hostilis Root and why is it in some versions of Mycolean’s ingredient list?
Mimosa Hostilis Root is a plant whose root bark contains trace DMT — a Schedule I compound — though the plant itself is not scheduled. It appears on Mycolean’s product page ingredient list but is absent from the FAQ’s official ingredient answer. This review documents the discrepancy without resolving it. Buyers seeking clarity should contact Myco Distribution LLC at support@mycolean.com before purchasing.
Why doesn’t Mycolean disclose per-ingredient dosages?
Myco Distribution LLC sells Mycolean as a proprietary blend without a publicly available Supplement Facts panel with dosages. This is legal under U.S. dietary supplement regulations but prevents independent evaluation of whether any ingredient is present at a clinically meaningful dose. No third-party testing document with individual dosage verification was accessible to Top Shelf Mushrooms at the time of this review.
Disclaimer: This content is for educational purposes only. Ingredient research discussed relates to compounds as studied in published scientific literature — not to the specific commercial product Mycolean unless explicitly stated. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare provider before beginning any supplement, particularly if you take prescription medications.
Leave a Reply